Literature DB >> 25314073

5-Aza-CdR delivers a gene body blow.

Sivakanthan Kasinathan1, Steven Henikoff2.   

Abstract

In this issue of Cancer Cell, Yang et al. describe a causal relationship between gene body methylation and gene expression and a role for genic methylation in response to clinical DNA methylation inhibitors, which suggests that the mechanism of action of these inhibitors includes gene body hypomethylation-induced downregulation of cancer-associated genes.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25314073      PMCID: PMC4322907          DOI: 10.1016/j.ccell.2014.09.004

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  10 in total

Review 1.  Functions of DNA methylation: islands, start sites, gene bodies and beyond.

Authors:  Peter A Jones
Journal:  Nat Rev Genet       Date:  2012-05-29       Impact factor: 53.242

2.  Gene body methylation can alter gene expression and is a therapeutic target in cancer.

Authors:  Xiaojing Yang; Han Han; Daniel D De Carvalho; Fides D Lay; Peter A Jones; Gangning Liang
Journal:  Cancer Cell       Date:  2014-09-25       Impact factor: 31.743

3.  DNA methylation profiling identifies CG methylation clusters in Arabidopsis genes.

Authors:  Robert K Tran; Jorja G Henikoff; Daniel Zilberman; Renata F Ditt; Steven E Jacobsen; Steven Henikoff
Journal:  Curr Biol       Date:  2005-01-26       Impact factor: 10.834

4.  Changes in H2A.Z occupancy and DNA methylation during B-cell lymphomagenesis.

Authors:  Melissa L Conerly; Sheila S Teves; Daniel Diolaiti; Michelle Ulrich; Robert N Eisenman; Steven Henikoff
Journal:  Genome Res       Date:  2010-08-13       Impact factor: 9.043

Review 5.  DNA methylation, H2A.Z, and the regulation of constitutive expression.

Authors:  D Coleman-Derr; D Zilberman
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2012-12-18

6.  Dynamic DNA methylation across diverse human cell lines and tissues.

Authors:  Katherine E Varley; Jason Gertz; Kevin M Bowling; Stephanie L Parker; Timothy E Reddy; Florencia Pauli-Behn; Marie K Cross; Brian A Williams; John A Stamatoyannopoulos; Gregory E Crawford; Devin M Absher; Barbara J Wold; Richard M Myers
Journal:  Genome Res       Date:  2013-01-16       Impact factor: 9.043

Review 7.  Intragenic DNA methylation: implications of this epigenetic mechanism for cancer research.

Authors:  N Shenker; J M Flanagan
Journal:  Br J Cancer       Date:  2011-12-13       Impact factor: 7.640

8.  Conserved role of intragenic DNA methylation in regulating alternative promoters.

Authors:  Alika K Maunakea; Raman P Nagarajan; Mikhail Bilenky; Tracy J Ballinger; Cletus D'Souza; Shaun D Fouse; Brett E Johnson; Chibo Hong; Cydney Nielsen; Yongjun Zhao; Gustavo Turecki; Allen Delaney; Richard Varhol; Nina Thiessen; Ksenya Shchors; Vivi M Heine; David H Rowitch; Xiaoyun Xing; Chris Fiore; Maximiliaan Schillebeeckx; Steven J M Jones; David Haussler; Marco A Marra; Martin Hirst; Ting Wang; Joseph F Costello
Journal:  Nature       Date:  2010-07-08       Impact factor: 49.962

9.  Histone H2A.Z and DNA methylation are mutually antagonistic chromatin marks.

Authors:  Daniel Zilberman; Devin Coleman-Derr; Tracy Ballinger; Steven Henikoff
Journal:  Nature       Date:  2008-09-24       Impact factor: 49.962

10.  DNA methylation and transcriptional noise.

Authors:  Iksoo Huh; Jia Zeng; Taesung Park; Soojin V Yi
Journal:  Epigenetics Chromatin       Date:  2013-04-26       Impact factor: 4.954

  10 in total
  2 in total

Review 1.  DNA methylation aberrancies as a guide for surveillance and treatment of human cancers.

Authors:  Gangning Liang; Daniel J Weisenberger
Journal:  Epigenetics       Date:  2017-03-30       Impact factor: 4.528

Review 2.  DNA methylation aberrancies delineate clinically distinct subsets of colorectal cancer and provide novel targets for epigenetic therapies.

Authors:  D J Weisenberger; G Liang; H-J Lenz
Journal:  Oncogene       Date:  2017-10-09       Impact factor: 9.867

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.